U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07081945) titled 'Prospective Study on the Use of hAM' on July 22.

Brief Summary: The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate whether hAM patch-assisted vitrectomy improves surgical success rate of retinal reattachment.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Rhegmatogenous Retinal Detachment

Intervention: DEVICE: hAM

The hAM stands for human amniotic membrane, which was used to seal inferior retinal breaks after complete vitrectomy.

Recruitment Status: RECRUITING

Sponsor: Eye & ENT Hospital of Fudan Universi...